Does PEMBROLIZUMAB Cause Hepatic function abnormal? 1,079 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,079 reports of Hepatic function abnormal have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 1.3% of all adverse event reports for PEMBROLIZUMAB.
1,079
Reports of Hepatic function abnormal with PEMBROLIZUMAB
1.3%
of all PEMBROLIZUMAB reports
180
Deaths
673
Hospitalizations
How Dangerous Is Hepatic function abnormal From PEMBROLIZUMAB?
Of the 1,079 reports, 180 (16.7%) resulted in death, 673 (62.4%) required hospitalization, and 100 (9.3%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
Yes, Hepatic function abnormal is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
CARBOPLATIN (498)
Which PEMBROLIZUMAB Alternatives Have Lower Hepatic function abnormal Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G